#c4therapeutics

  1. C4 Therapeutics and Merck KGaA Partner to Discover Protein Degraders Against Oncogenic Proteins

    By PharmaShots Shots: C4 Therapeutics and Merck KGaA have signed a strategic license & collaboration agreement for the discovery of two targeted protein degraders against oncogenic proteins of interest from the former’s internal discovery pipeline As per the agreement, C4T will ob
  2. US Stocks Edge Lower; Inflation Rate Slows to 3.1% In November

    By Avi Kapoor U.S. stocks traded slightly lower this morning, following the release of inflation data on Tuesday. Following the market opening Tuesday, the Dow traded down 0.04% to 36,389.01 while the NASDAQ fell 0.18% to 14,406.14. The S&P 500 also fell, dropping, 0.27% to 4,610.1